tiprankstipranks

Charles Baum Insider Profile

4 Followers
Charles Baum, Director at Array Biopharma, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 58.95K shares in Poseida Therapeutics (Ticker: PSTX), holds 0.00 shares in Immunomedics (Ticker: IMMU).
tipranks
Charles Baum

Charles Baum
Array Biopharma (~ARRY)
Director

Ranked #1,993 out of 98,564 Corporate Insiders

Profitable Transactions

63%
12 out of 19 Profitable Transactions

Average Return

+33.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$127K
100.00%
0.00%
0.00%
A breakdown of Charles Baum's holdings

Insider Roles

Poseida Therapeutics
(PSTX)
Director
PMV Pharmaceuticals
(PMVP)
Director
Acrivon Therapeutics, Inc.
(ACRV)
Director
Roles that Charles Baum holds in companies

Most Profitable Insider Trade

Stock:
Mirati Therapeutics
(MRTX)
Rating:Informative Buy
Date:Mar 30, 2020 - Mar 30, 2021
Return:+164.40%
The most profitable trade made by Charles Baum

Charles Baum's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ARRY
Array Biopharma
Jul 30, 2019
Uninformative Sell
720.00K
$0.00
IMMU
Immunomedics
Oct 23, 2020
Uninformative Sell
$0.00
PMV Pharmaceuticals
Director
Poseida Therapeutics
Jun 16, 2023
Director
Uninformative Buy
$127.33K
Acrivon Therapeutics, Inc.
Director
MRTX
Mirati Therapeutics
Jan 23, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Charles Baum's performance on stock

Charles Baum insider profile FAQ

What is the percentage of profitable transactions made by Charles Baum?
The percentage of profitable transactions made by Charles Baum is 63%.
    What is the average return per transaction made by Charles Baum?
    The average return per transaction made by Charles Baum is 33.10%.
      What stocks does Charles Baum hold?
      Charles Baum holds: ~ARRY, IMMU, PMVP, PSTX, ACRV, MRTX stocks.
        What was Charles Baum’s latest transaction?
        Charles Baum latest transaction was an Uninformative Sell of ―.
          What was Charles Baum's most profitable transaction?
          Charles Baum’s most profitable transaction was an Informative Buy of MRTX stock on March 30, 2020. The return on the trade was 164.40%.
            What is Charles Baum's role in Array Biopharma?
            Charles Baum's role in Array Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.